SCHEMBL664328

SCHEMBL664328

Cc1ccc(/N=C(\c2ccccc2)N(Cc2ccccc2)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.45
CNR2 P34972 1/20 0.43
TSPO P30536 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 2/20 0.41
PAX8 Q06710 2/20 0.41
GLA P06280 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.41
JAK2 O60674 1/20 0.40
CYP2D6 P10635 1/20 0.40
HIF1A Q16665 1/20 0.40
G6PC1 P35575 1/20 0.39
MAPT P10636 1/20 0.39
HTR3E A5X5Y0 1/20 0.39
SLC22A2 O15244 1/20 0.39
SLC22A1 O15245 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL664329 1.00 CYP2C19 (0.45) CYP2C19CNR2TSPONPC1RAB9A
SCHEMBL9804129 0.77 CYP2D6 (0.45) CYP2C19NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL22072470 0.73 CNR2 (0.47) CYP2C19CNR2TSPONPC1RAB9A
SCHEMBL12031549 0.73 NPC1 (0.67) CNR2TSPONPC1RAB9AALDH1A1
SCHEMBL20218944 0.73 LTB4R2 (0.62) CNR2NPC1RAB9AGAATSHR
SCHEMBL9804159 0.72 CYP2D6 (0.50) CYP2C19NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4237595 0.72 CNR2 (0.58) CYP2C19CNR2TSPONPC1RAB9A
SCHEMBL3060610 0.71 CYP2D6 (0.53) NPC1RAB9AALDH1A1SMN1; SMN2CYP2D6
SCHEMBL16382907 0.69 CYP2D6 (0.46) CNR2NPC1RAB9ASMN1; SMN2CYP2D6
SCHEMBL14176611 0.69 TSPO (0.73) CYP2C19CNR2TSPONPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846851-B2 Methods of ring opening polymerization and catalysts therefor INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-09-30 US claimed
US-20130158226-A1 METHODS OF RING OPENING POLYMERIZATION AND CATALYSTS THEREFOR INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-06-20 US claimed
US-20120046437-A1 METHODS OF RING OPENING POLYMERIZATION AND CATALYSTS THEREFOR INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-02-23 US claimed
US-8846851-B2 Methods of ring opening polymerization and catalysts therefor INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-09-30 US disclosed
US-8541477-B2 Methods of depolymerizing terephthalate polyesters INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-09-24 US disclosed
US-8507640-B2 Methods of ring opening polymerization and catalysts therefor INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-08-13 US disclosed
US-20130158226-A1 METHODS OF RING OPENING POLYMERIZATION AND CATALYSTS THEREFOR INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-06-20 US disclosed
WO-2012121985-A2 METHODS OF DEPOLYMERIZING TEREPHTHALATE POLYESTERS INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-09-13 WO disclosed
US-20120223270-A1 METHODS OF DEPOLYMERIZING TEREPHTHALATE POLYESTERS KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY (SA) 2012-09-06 US disclosed
US-20120046437-A1 METHODS OF RING OPENING POLYMERIZATION AND CATALYSTS THEREFOR INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120223270-A1 METHODS OF DEPOLYMERIZING TEREPHTHALATE POLYESTERS DDT, TRHDE, TERT CYP2C19 2313/4885CNR2 4618/4885TSPO 1859/4885
US-20120046437-A1 METHODS OF RING OPENING POLYMERIZATION AND CATALYSTS THEREFOR OGFOD1, PCNA, ODC1 CYP2C19 3758/4885CNR2 3807/4885TSPO 2136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.